Klaus Eistetter
Inventor
Stats
- 16 US patents issued
- 26 US Applications filed
- most recent filing
This is official USPTO record data
Details
- 16 US Patents Issued
- 26 US Applications Filed
- 159 Total Citation Count
- Jun 9, 2015 Most Recent Filing
- Jul 27, 1977 Earliest Filing
Work History
Patent Owner | Applications Filed | Year |
---|---|---|
NYCOMED GERMANY HOLDING GMBH | 1
| 2013
|
BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH | 2
1 2 1 1 | 1977
1978 1980 1981 1982 |
MediGene AG Gesellschaft fur Molekularbiologische Kardiologie und Onkologie | 1
| 1987
|
Regie Nationale des Usines Renault | 1
| 1982
|
HORST P.O. WOLF | 1
| 1987
|
NYCOMED GMBH | 1
1 | 2004
2006 |
TAKEDA GMBH | 1
1 1 1 1 | 1998
2004 2006 2010 2013 |
ATLANTA PHARMA AG | 1
| 2004
|
KLAUS EISTETTER BYK GULDEN LOMBERG CHEMISCHE FABRIK GMBH | 1
| 1987
|
WOLF, HORST P.O. | 1
| 1981
|
ASTRAZENECA AB | 1
1 1 1 2 3 3 | 1999
2002 2003 2004 2011 2013 2015 |
FRAUNHOFER-GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E.V. | 2
| 2006
|
Inventor Addresses
Address | Duration |
---|---|
Constance, DE | Apr 15, 80 - Jul 25, 17 |
Konstanz, DE | Feb 07, 84 - Oct 15, 15 |
Technology Profile
Technology | Matters | |
---|---|---|
A61K: | PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES | 24 |
A61M: | DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY | 1 |
A61P: | THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS | 3 |
Patents / Publication
Patents / Publication # | Year of Publication / Issued | Title | Citations |
---|---|---|---|
9713682 | 2017 | Device for dosing and dry nebulization | 12 |
9468598 | 2016 | Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient | 0 |
2015/0290,178 | 2015 | Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient | 1 |
2015/0290,179 | 2015 | Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient | 1 |
2015/0290,180 | 2015 | Oral Dosage Form Containing A PDE 4 Inhibitor as an Active Ingredient and Polyvinylpyrrolidon as Excipient | 1 |
We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level.
>
Upgrade to our Level for up to -1 portfolios!.